Zurich Cantonal Bank
ABBV icon

Zurich Cantonal Bank’s AbbVie ABBV Stock Holding History

Zurich Cantonal Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-666,741
Closed -$152M – 2550
2025
Q4 		$152M Buy
+666,741
New +$152M 0.33% 41

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Zurich Cantonal Bank's ABBV Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in AbbVie (ABBV) in Q1 2026: 660,576 shares worth $144M. The stake represents 0.31% of the portfolio and ranks #52 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in ABBV as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $215M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Zurich Cantonal Bank held 660,576 shares of AbbVie worth $144M as of Q1 2026.
  • AbbVie was a new Zurich Cantonal Bank position in Q1 2026.
  • AbbVie made up 0.31% of Zurich Cantonal Bank's portfolio in Q1 2026, its #52 holding.
  • Zurich Cantonal Bank first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • Zurich Cantonal Bank's AbbVie position peaked at $215M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.